The success rate in previous attempts at transforming human umbilical mesenchymal stem cells (HUMSCs) isolated from Wharton's jelly of the umbilical cord into dopaminergic cells was a mere 12.7%. The present study was therefore initiated to establish a more effective procedure for better yield of dopaminergic cells in such transformation for more effective HUMSC-based therapy for parkinsonism. To examine, in vitro, the effects of enhanced Nurr1 expression in HUMSCs on their differentiation, cells were processed through the three-stage differentiation protocol. The capacity of such cells to synthesize and release dopamine was measured by HPLC. The therapeutic effects of Nurr1-overexppressed HUMSCs were examined in 6-hydroxydopamine-lesioned rats by quantification of rotations in response to amphetamine. Enhanced Nurr1 expression in HUMSCs promoted the transformation into dopaminergic cells in vitro through stepwise culturing in sonic hedgehog, fibroblast growth factor-8, and neuron-conditioned medium. The success rate was about 71%, as determined by immunostaining for tyrosine hydroxylase and around 94 nM dopamine synthesis (intracellular and released into the culture medium), as measured by HPLC. Additionally, transplantation of such cells into the striatum of hemiparkinsonian rats resulted in improvement of their behavioral deficits, as indicated by amphetamine-evoked rotation scores. Viability of the transplanted cells lasted for at least 3 months as verified by positive staining for tyrosine hydroxylase. Nurr1, FGF8, Shh, and NCM can synergistically enhance the differentiation of HUMSCs into dopaminergic cells and may pave the way for HUMSC-based treatments for Parkinson's disease.
INTRODUCTION
Human umbilical mesenchymal stem cells (HUMSCs) possess stem cell properties (11, 24, 38) . They are notable for their ability to self-renew indefinitely and differentiate in vitro into multiple lineages (11, 24, 38) , including neuronal, osteogenic, chondrogenic, adipogenic, and myogenic cells. In a previous study, we demonstrated that HUMSCs could be transformed into dopaminergic cells (approximately 12.7%) through stepwise culturing in neuron-conditioned medium (NCM), sonic hedgehog (Shh), and fibroblast growth factor-8 (FGF8) (10). Transplantation of such cells into the striatum of hemiparkinsonian rats partially corrected the lesion-induced amphetamine-evoked rotation. A possible explanation for the incompleteness of the correction is that the quantity of transplanted cells may have been relatively inadequate and/or the proportion of cells transformed into dopaminergic cell was insufficient (10).
Nurr1, a member of the steroid/thyroid hormone receptor family, is a midbrain dopaminergic neuron-specific transcription factor (5, 31, 39) . It is not only essential for the generation of mesencephalic dopaminergic neurons as disclosed by studies of Nurr1-targeted mice (5, 31, (39) (40) (41) , it also regulates the synthesis and storage of dopamine (12) . A defect in the Nurr1 gene invokes the vulnerability of mesencephalic dopaminergic neurons to 1-methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP)induced insults (17) . Importantly, Nurr1 gene expression is significantly decreased in patients with Parkinson's disease (PD) (18, 22) . Several studies have indicated that the transduction of Nurr1 leads to the upregulation of dopaminergic markers tested and shows increased dopamine release in response to membrane depolarization in embryonic stem cells (ESCs) (7, 16) . All of these studies suggest Nurr1 is the most promising candidate in the development and functional maintenance of mesencephalic dopaminergic neurons (15) .
The objective of this study was to investigate if Nurr1 transduction might further increase the efficiency of the generation of dopaminergic cells from HUMSCs. Here we demonstrated that the generation of tyrosine hydroxylasepositive (TH + ) cells and the release of DA were effectively enhanced by Nurr1 overexpression when treated with the signaling molecules Shh, FGF8, and NCM. Transplantation of such cells into the striatum of hemiparkinsonian rats significantly improved the lesion-induced, amphetamineevoked rotation.
MATERIALS AND METHODS

Plasmid Construction and Transfection
To generate the pCMV-HA-Nurr1 plasmid, human Nurr1 cDNA was amplified and inserted into the Bgl II and Xho I sites of the pCMV-HA vector (#K6003-1; Clontech, Mountain View, CA, USA). The constructive plasmid was confirmed by restriction digestion and sequence analysis. After that, HUMSCs at a concentration of 5 × 10 5 cells were transfected with pCMV-HA or pCMV-HA-Nurr1 by electroporation (Amaxa Biosystems Nucleofector ® Device; Lonza, Cologne, Germany) using Human MSC Nucleofector TM Kit (Amaxa #VPE-1001; Lonza). Briefly, cells were resuspen ded in transfection buffer (Amaxa #VPE-1001; Lonza), and then transferred to a sterile cuvette (Amaxa #VPE-1001; Lonza). Subsequently, cells were incubated with 2 µg pCMV-HA-Nurr1 or pCMV-HA and electroporated via a high transfection efficiency program, rinsed with sterile culture medium (21870-076; Gibco), and finally transferred to a culture dish.
Cultivation and Differentiation of HUMSCs
With the written consent of the parents, fresh human umbilical cords (n = 10) from both sexes were obtained after birth and collected in Hank's balanced salt solution (14185-052; Gibco) at 4°C. HUMSCs were obtained and propagated as in a previous study (10), with some modifications (Fig. 1A) . Sprague-Dawley rats at the age of 7 days were deeply anesthetized by intraperitoneal injection of 10% chloride hydrate, and their brains were removed and triturated in Ca 2+ /Mg 2+ -free buffer. The dissociated cells were resuspended in 10% fetal bovine serum in Dulbecco modified Eagle medium (DMEM; 12100-046; Gibco) and incubated at 37°C. The medium was collected 5 days later as neuron-conditioned medi um (NCM) for the culture of HUMSCs (20). First, HUMSCs were transfected with pCMV-HA or pCMV-HA-Nurr1. After 24 h of cultivation, Nurr1-transfected HUMSCs were separated into four groups: DMEM 9 days; NCM 9 days; NCM 6 days followed by FGF8 (100 ng/ml, 423-F8; R&D Systems, Minneapolis, MN, USA) + Shh (500 ng/ml, 461-SH; R&D Systems) 3 days; and finally, FGF8 + Shh 3 days then NCM 6 days. Vector-transfected HUMSCs were separated into two groups: NCM 6 days later then FGF8 + Shh 3 days and FGF8 + Shh 3 days followed by NCM 6 days.
RNA Preparation and RT-PCR
Total RNA purification and RT-PCR was performed as described previously (35). The primer sequences were as follows: Nurr1, 5′-AGTATGGGTCCTCGCCTCAA-3′ and 5′-ATTCTCCCGAAGAGTGGTAACTGT-3′; TH, 5′-TG TCCACGCTGTACTGGTTCAC-3′ and 5′-GTCGAAGG CCCGAATCTCA-3′; AADC, 5′-ACAGACTTAACGGG AGCCTTTAGA-3′ and 5′-GTGATAAGCCCTGAATCC TGATG-3′; DAT, 5′-CATAGACGGCATCAGAGCATA CC-3′ and 5′-CCGCGTCAATCCAAACAGA-3′; GAPDH, 5′-TGG TATCGTGGAAGGACTCA-3′ and 5′-AGTGGGT GTCGCTGTTGAAG-3′.
Immunofluorescence of Tyrosine Hydroxylase (TH)
HUMSCs and brain sections were fixed with 4% paraformaldehyde (Sigma-Aldrich) in 0.1 M phosphate buffer for 20 min and washed with 0.1 M phosphate buffer (Sigma-Aldrich). They were then treated with a blocking solution [0.05% Triton X-100 (Sigma-Aldrich), 5% normal goat serum (S-1000; Vector Laboratories, Burlingame, CA, USA), and 3% bovine serum albumin (Sigma-Aldrich)] for 30 min to prevent nonspecific antibody-antigen binding. The cells and brain sections were then reacted with primary antibodies (mouse anti-TH, 1:333, MAB318; Chemicon, Temecula, CA, USA) at 4°C for 18 h, washed with 0.1 M phosphate-buffered saline (PBS; Sigma-Aldrich), reacted with secondary antibodies (all from Chemicon) at room temperature for 1 h, and washed again with 0.1 M PBS. Brain sections were reacted with ABC complex (ABC KIT, PK-4000; Vector Laboratories) at room temperature for 1 h, washed with 0.1 M PBS, and finally developed with 3,3′-diaminobenzidine (DAB, Sigma-Aldrich) (5 mg DAB, 3.5 µl of 30% H 2 O 2 in 10 ml of 50 mM Tris buffer). HUMSCs were reacted with secondary antibodies (Rhodamine-conjugated goat anti-mouse IgG for TH, 1:250, AP124R; Chemicon) at room temperature for 1 h, washed again with PBS, incubated with 4′,6-diamidino-2-phenylindole dihydrochloride (DAPI; Sigma-Aldrich) to stain the nucleus, and finally observed under a fluorescence microscope. TH + cells were manually counted by researchers blinded to the treatment groups. Quantitative immunocytochemical data represent means and standard errors from more than 200 cells counted in 10 randomly sampled fields of six separate samples.
Western Blotting for TH
Western blot analysis was performed according to a procedure outlined in our previous study (6). Cell membranes were prepared from HUMSCs cultured in NCM, Shh, and FGF8 for varying periods. After resolution on 20% SDS-PAGE (Level Biotechnology), the cell proteins were blotted onto polyvinylidene difluoride membranes (Millipore Corporation, Bedford, MA, USA), which were then washed with Tris buffer (Sigma-Aldrich) with 0.9% NaCl (pH 7.3), immersed in the blocking solution (0.05% Triton X-100, 5% normal goat serum, and 3% bovine serum albumin) for 60 min, washed with Tris-buffered saline again, and reacted with primary Vector-expressing HUMSCs cultured in FGF8 + Shh for 3 days and then NCM for 6 days. (c) Nurr1expressing HUMSCs cultured in FGF8 + Shh for 3 days and then NCM for 6 days. (d) Nurr1-expressing HUMSCs cultured in NCM for 6 days and then FGF8 + Shh for 3 days. After 9 days of differentiation, morphological changes were observed in Nurr1-expressing HUMSCs by phase contrast microscopy. Undifferentiated cells showed fibroblast-like shape morphology, whereas Nurr1-expressing cells protruded, exhibiting an elongation of neurite-like process (arrows). Scale bar: 100 µm.
antibodies (mouse anti-TH, 1:333, MAB318; Chemicon) at 4°C for 12 to 18 h. After the reaction was completed, the polyvinylidene difluoride membranes were washed with Triton Tris buffer [0.05% Triton and 0.9% NaCl (Sigma-Aldrich) in 50 mM Tris-HCl, pH 7.3], immersed in the blocking solution for 60 min, and then reacted with secondary antibodies (biotin-conjugated goat antimouse-IgG, 1:300, AP124B; Chemicon) at room temperature for 1 h. The PVDF membranes containing the reaction products were washed with Tris-buffered salt solution with Tween (Sigma-Aldrich) (TTBS), reacted with ABC complex (PK-4000; Vector Laboratories) at room temperature for 1 h, washed again with TTBS, and finally developed with DAB.
Analysis of Dopamine Concentration by High-Performance Liquid Chromatography (HPLC)
For the measurement of the concentration of dopamine (DA), 3,4-dihydroxyphenylacetic acid (DOPAC), 5-hydroxyindole acetic acid (5-HIAA), homovanillic acid (HVA), and serotonin (5-HT), cell pellet and the culture medium were acidified with perchloric acid (Sigma-Aldrich) and centrifuged at 10,000 × g for 10 min. The supernatant was immediately frozen in liquid nitrogen and stored at −70°C until analysis. Samples were purified using a 0.22-µm nylon filter (Merck Millipore) before being assayed for their dopamine contents by reverse-phase HPLC (Shimazu, Kyoto, Japan) using a 4.6 × 150-mm C18 column (Agilent, Palo Alto, CA, USA). Other conditions were the same as in a previous study (10).
Preparation and Grouping of Hemiparkinsonian Animals
All procedures involving animals were performed in accordance with the institutional animal welfare guidelines of the College of Medicine at the National Yang-Ming University. Adult male Sprague-Dawley rats were obtained from the Laboratory Animal Center at National Yang-Ming University. All experimental rats received the unilateral lesions by the injections of 6 µl 6-hydroxydopamine (6-OHDA; 6 µg/µl in normal saline containing 0.02% ascorbic acid) into the median forebrain bundle (A/P: −4.3 mm, R/L: +1.6 mm, H: −8.2 mm) and substantia nigra (A/P: −4.8 mm, R/L: +1.5 mm, H: −8.2 mm). After 6-OHDA injection, amphetamine-induced rotational behavior was assessed at 1 to 4 months. For the rotational behavior test, the rats were placed in individual plastic hemispherical bowls from automated rotometer system (MED Associates, Inc., St. Albans, VT, USA) and allowed to habituate for 10 min before being injected with a subcutaneous dose of amphetamine (2.5 mg/kg; Sigma-Aldrich). Left and right full-body turns were counted. Amphetamine-induced net rotation over a period of 60 min, starting 30 min after injection, was enumerated. Animals showing >6 turns per minute ipsilaterally toward the lesioned side after a single dose of amphetamine were considered successful hemiparkinsonian models and were selected for grafting (2, 36, 37) . All behavioral tests were performed in a closed room to avoid any environmental disturbance and assessed by an independent observer blind to the treatments.
One month after 6-OHDA lesion, rats were divided into four experimental groups on the basis of different treatments: (1) parkinsonian group (PD group, n = 6), with 6-OHDA lesion-induced hemiparkinsonism and received PBS only in the lesioned striata; (2) rats (n = 6) with 6-OHDA lesion-induced hemiparkinsonism and receiving a suspension of 4 × 10 5 graft cells that had been transfected with vector alone, and cultured in FGF8 + Shh 3 days then NCM 6 days [referred to as PD + Vector + FGF8 + Shh 3d + NCM 6d (4 × 10 5 ) group];
(3) rats (n = 6) with 6-OHDA lesion-induced hemiparkinsonism and receiving a sus pension of 1 × 10 5 graft cells, which had been transfected with Nurr1, and cultured in FGF8 + Shh 3 days followed by NCM 6 days [referred to as PD + Nurr1 + FGF8 + Shh 3d + NCM 6d (1 × 10 5 cells) group]; (4) rats (n = 6) with 6-OHDA lesion-induced hemiparkinsonism and receiving a suspension of 4 × 10 5 graft cells, which had been transfected with Nurr1, and cultured in FGF8 + Shh 3 days followed by NCM 6 days [referred to as PD + Nurr1 + FGF8 + Shh 3d + NCM 6d (4 × 10 5 cells) group]. Histological examinations of grafted cryosections were carried out according to procedures outlined in a previous study (10).
Preparation and Transplantation of HUMSC-Derived TH + Cells
The HUMSCs after in vitro differentiation were treated with 1 µg/ml bis-Benzimide (B2883; Sigma-Aldrich) for 24 h to label the cells. Cells were trypsinized at 37°C for 5 min with 0.25% trypsin (15090-046; Gibco), and the dissociated cells were resuspended in PBS. Animals were implanted with a total of 10 µl of PBS containing 1 × 10 5 or 4 × 10 5 cells, deposited at two stereotaxic levels (anterior, 1.0 mm; lateral, 3.0 mm; ventral, −6.0 mm and −5.0 mm) in the striatum on the side ipsilateral to the 6-OHDA lesion. The Hamilton syringe with a 22-gauge needle was left in situ for further 10 min to avoid reflux along the inoculation track. Rat hosts did not receive any immunosuppression medications.
Statistical Analyses
Values are expressed as the mean ± standard error of the mean. One-way or two-way analysis of variance was used to compare all means, and Tukey's test was used for the posteriori tests. A value of p < 0.05 was considered statistically significant.
RESULTS
Acquisition of Dopaminergic Phenotype From Nurr1-Expressing HUMSCs Treated With NCM, FGF8, and Shh
HUMSCs were transfected with either the Nurr1expressing vector (pCMV-HA-Nurr1) or the (empty) (sham) vector (pCMV-HA-vector) serving as a vehicle. Q-PCR analysis showed that Nurr1 expression was increased about 40-fold in Nurr1-transduced HUMSCs after 24-h modification (Fig. 1B) . The untreated umbilical mesenchymal stem cells appeared mostly spindle shaped and were closely apposed to each other due to proliferation following treatment with DMEM for 9 days (Fig. 1Ca ). After 9 days of differentiation, vector-and Nurr1-expressing HUMSCs all developed smaller cell bodies, but Nurr1-expressing cells exhibited more elongation of neurite-like processes (Fig. 1Cb, c, d) . These processes were exceedingly long and had formed cellcell contacts.
To address whether Nurr1 expression enhancement could enhance in vitro differentiation of HUMSCs into dopaminergic cells, the catecholaminergic marker of the rate-limiting synthesizing enzyme TH in these cells was monitored by immunocytochemical staining. The proportion of vehicle vector cells expressing TH was 2.50 ± 0.31% after treatment with DMEM for 3 days (Fig. 2Aa,  B ). That percentage was increased to 25.05 ± 0.74% after treatment with NCM for 6 days and Shh + FGF8 for 3 days (Fig. 2Ab, B ). Nurr1 expression enhancement alone promoted an increase in the percentage of TH + cells to 29.19 ± 0.60% in the group cultured in DMEM for 3 days. Further incubation of up to 9 days under the same condition (DMEM only) did not increase further the number of TH + cells (Fig. 2Ac, B ). In the NCM and FGF8 + Shh groups, the data showed that as the incubation time increased, the number of TH + cells also gradually increased for up to 9 days in the enhanced Nurr1 expression groups. Among those, combined treatments of NCM for 6 days and FGF8 + Shh for 3 days could increase the number of TH + cells to 70.5 ± 4.34% (Fig. 2Ae, B) . The success rate in the differentiation of TH + cells increased 2.8-fold compared to the vehicle vector groups that underwent the same procedure. No differ ence in the proportion of TH-expressing cells was observed between different orders of NCM and FGF8 + Shh (Fig. 2B) .
Western blotting showed similar results as the analyses of immunocytochemical staining (Fig. 2C) . The protein level of TH in the Nurr1-expressing group combined treatment of NCM for 6 days and FGF8 + Shh for 3 days has significantly increased 1.8-fold in contrast to the vehicle vector group.
To further characterize the Nurr1-mediated induction of dopaminergic cells, real-time PCR was used to evaluate the expressions of specific genes involved in dopamine synthesis and transport. The mRNA expression of TH, l-aromatic amino acid decarboxylase (AADC), and DA transporter (DAT) were all upregulated in differentiated HUMSCs compared with untreated HUMSCs. The expression level of Nurr1-transduced groups was significantly higher than in the vector-transduced groups (Fig. 3A) .
Since dopamine release is a definitive characteris tic for the identification of dopaminergic cells, we evaluated the Figure 3 . Effect of Nurr1, FGF8 + Shh, and NCM can synergistically enhance the generation of dopaminergic neuron-specific genes and the release of dopamine. (A) Real-time PCR analyses for the genes specific to DA synthesis and transport. Histograms demonstrate the relative expressions of TH, AADC, and DAT mRNA in cultures of HUMSCs cultured in FGF8 + Shh for 3 days followed by NCM for 6 days after Nurr1 transduction. The expressions of mRNA of such genes were all significantly increased in differentiated HUMSCs compared with untreated HUMSCs. The expression levels in Nurr1-expressing groups were significantly higher than those in the vectorexpressing groups. *Statistical difference at p < 0.05 compared with untreated groups. #Statistical difference at p < 0.05 compared with vector and untreated groups. HPLC quantification of dopamine in cultured medium (B) and cells (C). After stepwise differentiation, dopamine concentrations were evaluated in each condition by reverse-phase HPLC. The results showed more amounts of dopamine in the cell-transduced Nurr1 and cultured in NCM and FGF8 + Shh for 9 days. Results represent the mean ± standard error from four different experiments. *Statistical difference at p < 0.05 compared with the other groups in (B). *Significant difference at p < 0.05 compared with untreated group. #Significant difference at p < 0.05 between the Nurr1 and vector groups in the same condition in (C). dopamine concentration by using reverse-phase high-performance liquid chromatography (HPLC). Dopa mine was below detection in the medium of untreated HUMSCs cultured in DMEM. The dopamine concentrations of the conditioned media were between 2.28 ± 0.46 and 4.74 ± 0.08 ng/ml in the vector-expressing HUMSCs after a 3-to 9-day differentiation culture (NCM and FGF8 + Shh treatment) of 10 5 cells in a 100-mm culture dish. Dopamine level was not further augmented in the conditioned media prepared from Nurr1-expressing HUMSCs treated with NCM for 3 or 6 days, and/or FGF8 + Shh for 3 days, compared with the vector-expressing groups. However, dopamine release into the media of HUMSCs treated with FGF8 + Shh for 3 days and then NCM for 3 or 6 days yielded 11.39 ± 1.02 and 11.78 ± 1.12 ng/ml/10 5 cells, respectively (Fig. 3B ). Furthermore, dopamine was still detectable in the cell pellets of cells collected following 9 days of differentiation even after release stimulation. In untreated HUMSCs, total DA contents were only 0.013 ± 0.003 ng/ml. In contrast, dopamine concentrations in differentiated cells rose to concentrations of between 1.03 ± 0.27 and 2.58 ± 0.18 ng/ml after a 9-day culture. More importantly, dopamine levels in the Nurr1-expressing groups were significantly higher than those in the vectorexpressing groups (Fig. 3C) .
Since previous literature reported that serotonin may play as a modulator for the synthesis and release of dopamine (9, 13, 25, 26) , we evaluated the serotonin concentration by using reverse-phase HPLC (Fig. 4A, B) . Serotonin was hardly detected in the medium of untreated HUMSCs cultured in DMEM. The serotonin concentrations of the conditioned media were between 2.41 ± 1.67 and 10.76 ± 5.65 ng/ml in the vector-expressing HUMSCs after a 3-to 9-day differentiation culture (NCM and FGF8 + Shh treatment) of 10 5 cells in a 100-mm culture dish. Serotonin level was not further augmented in the conditioned media prepared from Nurr1-expressing HUMSCs treated with NCM for 3 or 6 days, and/or FGF8 + Shh for 3 or 6 days, compared with the vectorexpressing groups (Fig. 4C ). Furthermore, serotonin was still detectable in the cell pellets of cells collected following 9 days of differentiation even after release stimulation. In untreated HUMSCs, total serotonin contents were only 0.52 ± 0.17 ng/ml. In contrast, serotonin concentrations in the vector-expressing HUMSCs after a 9-day differentiation rose to concentrations of between 7.05 ± 2.60 and 9.36 ± 3.80 ng/ml. However, serotonin concentration in Nurr1-expressing HUMSCs treated with NCM for 6 days and then FGF8 + Shh for 3 days was 6.36 ± 2.20 ng/ml. More interesting, serotonin levels in the Nurr1expressing HUMSCs pretreated with FGF8 + Shh for 3 days and then NCM for 6 days were significantly higher to 22.00 ± 11.82 ng/ ml (Fig. 4D) .
Dopaminergic Cells Differentiated From HUMSCs Exist in Grafted Striatum
At 3 months after transplantation, bis-Benzamidelabeled cells were found in and around the implantation sites (Fig. 5A, B) . Anatomical examinations revealed that many cells whose somata and process stained positively for TH were found in 6-OHDA-lesioned striatum ( Fig. 5C ). Cell migration patterns were followed by bis-Benzimide labeling in 30-µm serial sections. The labeled cells had migrated for approximately 2.8 mm in both directions of the rostrocaudal axis from the implantation site (bregma 1.0). Most of the labeled cells were localized in the region of bregma −1.0 to the region of bregma 1.8, almost throughout the entire striatum (Fig. 5D ).
Effect of Transplantation on Amphetamine-Induced Rotation
The effects of cell transplantation were evaluated in 6-OHDA-lesioned rats by quantification of rotations in response to amphetamine. Rotational scores were examined at 1, 2, 3, and 4 months post-6-OHDA lesioning. One month after lesioning, the numbers of amphetamine-induced rotations in all groups reached to between 6.40 ± 0.19 and 6.82 ± 0.56 rotations per minute. The PD group, which received injections of PBS in the dopamine-denervated striatum, showed a gradual but significant increase in the numbers of rotations over the observation period. By contrast, rotations in all of the PD animals that received grafts of 4 × 10 5 vector-transduced cells preconditioned by being cultured in FGF8 + Shh for 3 days followed by NCM for Figure 5 . Photomicrographs showing the distribution of implanted HUMSCs in hemiparkinsonian rats 3 months after transplantation. Following labeling of the cell nuclei with bis-Benzamide, HUMSCs were microinjected into the striata of hemiparkinsonian rats. The cells survived in the striata 3 months after transplantation. Phase-contrast (A) and same field (B) fluorescence photomicrograph. Scale bar: 1 mm. (C) Existence of TH + cell bodies and its processes (arrows) in the grafted striatum. Scale bar: 50 µm. (D) Line drawings of rat brain demonstrating the extent of HUMSC migration after implantation in the striatum of the rat at the bregma level. Cells of bis-Benzamide-labeled HUMSCs. 6 days did not continue to get worse throughout the observation period as in the case of the PD group. Similar patterns were found in all of the PD animals receiving grafts of 1 × 10 5 of the same preconditioned Nurr1-expressing cells and treated with FGF8 + Shh for 3 days followed by NCM for 6 days. Among the grafted categories, the group that received a graft of 4 × 10 5 of the preconditioned Nurr1expressing HUMSCs previously treated by FGF8 + Shh for 3 days followed by NCM for 6 days made a marked recovery in rotational scores (Fig. 6 ).
DISCUSSION
In this study, we accomplished a high percentage of the differentiation of HUMSCs into dopaminergic cells by combining Nurr1 manipulation and our previously developed culturing conditions (10). The transplantation of grafts of Nurr1-expressing HUMSCs preconditioned by culturing in FGF8 + Shh and followed by treatment of NCM successfully decreased amphetamine induced rotational behavior in hemiparkisonian rats.
Our results show that enhanced expression of Nurr1 increased the percentage of TH + cells from 2.5% to 29% of total differentiated cells following culturing in 10% FBS-DMEM for 3 days. The number of TH-expressing cells was not further increased even when the observation time was increased to 9 days. The effects of Nurr1 modification alone are only moderate in the generation of dopaminergic cells from HUMSCs. Other signaling molecules are required. Conditioning with FGF8, Shh, and NCM significantly increased the proportion of TH + cells around 64-71%. These results indicate that Nurr1 and FGF8 + Shh can synergistically enhance the differentiation of HUMSCs into dopaminergic cells. Moreover, the amount of dopamine released into the media could be strikingly increased if FGF8 and Shh were prepared at the beginning of the process, suggesting that FGF8 and Shh could affect, at an early stage, the success of implanted cells in rescuing midbrain dopaminergic functions, as reported in a previous study (14) .
The rotation behavior in the PD group continued to deteriorate with time. In contrast, no increase in rotation that did not continue to get worse like the PD (lesionedonly) group was observed 1 month after transplantation in the two groups, those received grafts of 4 × 10 5 vector-transduced cells preconditioned by being cultured in FGF8 + Shh followed by NCM and received grafts Figure 6 . Time course of amphetamine-induced rotation response. Rotation scores were evaluated at 1 to 3 months posttransplantation. A significant decrease in the number of amphetamine-induced tuning was observed in the rats receiving a graft of 4 × 10 5 Nurr1expressing HUMSCs cultured in FGF8 + Shh for 3 days followed by NCM for 6 days at all time points after transplantation. *Significant difference at p < 0.05 compared with the PD group at the same time point. #Significant difference at p < 0.05 compared with the PD + vector + FGF + Shh 3d + NCM 6d (4 × 10 5 cells) at the same time point. ♠Significant difference at p < 0.05 compared with the PD + Nurr1 + FGF + Shh 3d + NCM 6d (1 × 10 5 cells) at the same time point. of 1 × 10 5 Nurr1-expressing cells and pretreated with FGF8 + Shh and followed by NCM. Subsequently, for the next 2 months, neither significant further improvements (reduction) nor deteriorations (elevation) were observed. Besides, the rotation in the 4 × 10 5 Nurr1-expressing cell group was significantly decreased relative to the levels of the control group and the other two transplanted groups, back to <6 turns per minute at 1 month after transplantation (under the turns of definition of PD models) (2, 36, 37) . Such tendency was persistent for at least 3 months after implantation. Although not to the extent of returning to the normal level, there was significant improvement in the rotational behavior (50.8% decrease, from 9.02 turns down to 4.44 turns per minute). We suggest that the number of dopaminergic cells of implanted cells may have been relatively inadequate.
The cell replacement strategy in PD treatment is based on the idea that the impaired dopamine neurotransmission in the striatum can be restored by the grafts (21). In agreement with this, the amount of dopamine synthesis and release from implanted cells is essential to treatment for PD. In this study, dopamine release into the media of HUMSCs pretreated with FGF8 + Shh for 3 days and then NCM for 6 days yielded 12 ng/ml/10 5 cells (about 77 nM/10 5 cells). Besides, approximately 3 ng/ml dopamine (17 nM dopamine) was still detectable in the cell pellets after release stimulation. Total dopamine production after a 9-day culture reaches the peak of 94 nM in our study. Our result appears a higher level in dopamine synthesis compared with the previous studies (1, 19, 23, 29) . Almost 1.5 nM dopamine released from human fetal ventral midbrain neural stem cells treatment with Wnt5a signal (29). About 80 pg/ml dopamine was synthesized from reprogrammed human fibroblasts (23). Approximately 650 pg/ml dopamine was produced from Nurr1-overexpressing murine embryonic stem cells (1). The amount of 15 ng/ml dopamine was released from hepatocyte growth factor-transducing HUMSCs (19). Many attempts have been made in order to improve the dopaminergic function of implanted cells.
Moreover, studies have reported that serotonin enhances striatal dopamine outflow (9, 13, 26) . In our study, serotonin levels in the Nurr1-expressing HUMSCs pretreated with FGF8 + Shh for 3 days and then NCM for 6 days were significantly higher than other groups, indicating that the presence of serotonin may exert and be beneficial for dopamine-mediated behaviors.
The grafted dopamine neurons can survive and become functionally integrated into neuronal circuitries in the striatum despite ongoing disease processes (28). However, the inaccessibility of such tissue severely limits their clinical utility. Furthermore, in contrast to embryonic stem cells and induced pluripotent stem cells, MSCs do not carry teratoma-producing properties. Interestingly, unlike bone marrow MSCs (BMMSCs), HUMSCs do not transform to tumor-associated fibroblasts in the presence of breast and ovarian cancer cells (32). These suggest that HUMSCs can be an important alternative source of stem cells and deserve to be examined in long-term clinical trials (4).
In a recent report, Datta and colleagues maintained that human Wharton's jelly-derived MSCs possess neuronal plasticity for a dopaminergic cell type that is comparable to BMMSCs (8). The HUMSCs are collected from the Wharton's jelly of the umbilical cord, which is generally considered to be a "leftover" after childbirth and can be obtained with little effort. These cells have the multipotent differentiation ability and are regarded as having low immunogenicity (4, 33, 34) . In addition, HUMSCs enable the usage of autologous transplantation, thus avoiding the risk of immune rejection. Compared with BMMSCs, a stem cell marker analysis by Nekanti et al. showed that Wharton's jelly MSCs express more embryonic stem cell markers and possess properties of true stem cells, which they retain even after extended in vitro culturing (27). HUMSCs bear a relatively higher proliferative potential and telomerase activity than BMMSCs (3,30). Thus, Wharton's jelly MSCs seem to be more primordial than cells found in the bone marrow and have generated remarkable interests in their potential therapeutic values.
CONCLUSION
HUMSCs were induced to differentiate into TH + cells in vitro using a three-step protocol. The enhanced Nurr1expressing HUMSCs were generated in stage 1 and differentiated into dopaminergic cells during culturing in Shh and FGF8 in stage 2 and in NCM in stage 3. The process yielded a highly efficient generation of dopaminergic cells (up to 70%) and their production of dopamine (approximately 94 nM). Transplantation of such cells into the striatum of hemiparkinsonian rats helped to improve dopaminergic functions in the hemisparkinsonian rats as indicated by correction of the lesion-induced amphetamine-evoked rotation.
